AstraZeneca PLC is 7.4x more valuable than ALNYLAM PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $38.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALNY | AZN |
|---|---|---|
| Market cap | $38.52 B | $286.27 B |
| US-listed rank | #396 | #45 |
| Revenue (latest FY) | $3.71B | - |
| Net income (latest FY) | $313.75M | - |
| Net margin | 8.4% | - |
| P/E (trailing FY) | 122.8 | - |
| SEC filings | 1,651 | 1,004 |
AstraZeneca PLC is 7.4x more valuable than ALNYLAM PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $38.52 B).
Full pages: ALNYLAM PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.